222 related articles for article (PubMed ID: 35661084)
1. Biocompatible Cationic Lipoamino Acids as Counterions for Oral Administration of API-Ionic Liquids.
Lai A; Leong N; Zheng D; Ford L; Nguyen TH; Williams HD; Benameur H; Scammells PJ; Porter CJH
Pharm Res; 2022 Oct; 39(10):2405-2419. PubMed ID: 35661084
[TBL] [Abstract][Full Text] [Related]
2. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
[TBL] [Abstract][Full Text] [Related]
3. Ionic Liquid Forms of Weakly Acidic Drugs in Oral Lipid Formulations: Preparation, Characterization, in Vitro Digestion, and in Vivo Absorption Studies.
Sahbaz Y; Nguyen TH; Ford L; McEvoy CL; Williams HD; Scammells PJ; Porter CJH
Mol Pharm; 2017 Nov; 14(11):3669-3683. PubMed ID: 28954512
[TBL] [Abstract][Full Text] [Related]
4. Stabilising disproportionation of lipophilic ionic liquid salts in lipid-based formulations.
Lai A; Sahbaz Y; Ford L; Nguyen TH; Haque S; Williams HD; Benameur H; Scammells PJ; Porter CJH
Int J Pharm; 2021 Mar; 597():120292. PubMed ID: 33581479
[TBL] [Abstract][Full Text] [Related]
5. API ionic liquids: probing the effect of counterion structure on physical form and lipid solubility.
Ford L; Tay E; Nguyen TH; Williams HD; Benameur H; Scammells PJ; Porter CJH
RSC Adv; 2020 Mar; 10(22):12788-12799. PubMed ID: 35492138
[TBL] [Abstract][Full Text] [Related]
6. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
[TBL] [Abstract][Full Text] [Related]
7. 50years of oral lipid-based formulations: Provenance, progress and future perspectives.
Feeney OM; Crum MF; McEvoy CL; Trevaskis NL; Williams HD; Pouton CW; Charman WN; Bergström CAS; Porter CJH
Adv Drug Deliv Rev; 2016 Jun; 101():167-194. PubMed ID: 27089810
[TBL] [Abstract][Full Text] [Related]
8. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
Feeney OM; Williams HD; Pouton CW; Porter CJ
J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
[TBL] [Abstract][Full Text] [Related]
9. Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure.
Tay E; Nguyen TH; Ford L; Williams HD; Benameur H; Scammells PJ; Porter CJH
Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31877828
[TBL] [Abstract][Full Text] [Related]
10. Polyvinylidene fluoride-Hyaluronic acid wound dressing comprised of ionic liquids for controlled drug delivery and dual therapeutic behavior.
Abednejad A; Ghaee A; Morais ES; Sharma M; Neves BM; Freire MG; Nourmohammadi J; Mehrizi AA
Acta Biomater; 2019 Dec; 100():142-157. PubMed ID: 31586728
[TBL] [Abstract][Full Text] [Related]
11. Ionic Liquids: Promising Approach for Oral Drug Delivery.
Jiang L; Sun Y; Lu A; Wang X; Shi Y
Pharm Res; 2022 Oct; 39(10):2353-2365. PubMed ID: 35449344
[TBL] [Abstract][Full Text] [Related]
12. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system.
Williams HD; Sassene P; Kleberg K; Calderone M; Igonin A; Jule E; Vertommen J; Blundell R; Benameur H; Müllertz A; Porter CJ; Pouton CW;
J Pharm Sci; 2014 Aug; 103(8):2441-55. PubMed ID: 24985238
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Review on Imperative Role of Ionic Liquids in Pharmaceutical Sciences.
Uniyal P; Das S; Panwar S; Kukreti N; Nainwal P; Bhatia R
Curr Drug Deliv; 2024; 21(9):1197-1210. PubMed ID: 37815183
[TBL] [Abstract][Full Text] [Related]
14. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
[TBL] [Abstract][Full Text] [Related]
15. Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.
Stocker MW; Healy AM; Ferguson S
Mol Pharm; 2020 Sep; 17(9):3412-3424. PubMed ID: 32852215
[TBL] [Abstract][Full Text] [Related]
16. Characterization and cytotoxicity evaluation of biocompatible amino acid esters used to convert salicylic acid into ionic liquids.
Moshikur RM; Chowdhury MR; Wakabayashi R; Tahara Y; Moniruzzaman M; Goto M
Int J Pharm; 2018 Jul; 546(1-2):31-38. PubMed ID: 29751143
[TBL] [Abstract][Full Text] [Related]
17. The molecular design of drug-ionic liquids for transdermal drug delivery: Mechanistic study of counterions structure on complex formation and skin permeation.
Yang D; Liu C; Ding D; Quan P; Fang L
Int J Pharm; 2021 Jun; 602():120560. PubMed ID: 33798684
[TBL] [Abstract][Full Text] [Related]
18. Unlocking the full potential of lipid-based formulations using lipophilic salt/ionic liquid forms.
Williams HD; Ford L; Igonin A; Shan Z; Botti P; Morgen MM; Hu G; Pouton CW; Scammells PJ; Porter CJH; Benameur H
Adv Drug Deliv Rev; 2019 Mar; 142():75-90. PubMed ID: 31150666
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Biocompatible Ionic Liquids in Drug Formulation and Delivery.
Moshikur RM; Carrier RL; Moniruzzaman M; Goto M
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111664
[TBL] [Abstract][Full Text] [Related]
20. Rationalizing Counterion Selection for the Development of Lipophilic Salts: A Case Study with Venetoclax.
Ryan CD; Griffin BT; O'Shea JP
Mol Pharm; 2024 Jun; 21(6):2981-2992. PubMed ID: 38703358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
